A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers.

The efficacy of interferon A (rIFN-alpha 2A), an Escherichia coli-derived interferon, in the prophylaxis of acute upper respiratory tract infection, was evaluated in a community-based double-blind placebo-controlled study in the Australian winter of 1985. The trial population of 412 healthy voluntee...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tannock, G. A., Gillett, S. M., Gillett, R. S., Barry, R. D., Hensley, M. J., Herd, R., Reid, A. L., Saunders, N. A.
Format: Artigo
Jezik:Inglês
Izdano: Cambridge University Press 1988
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2249423/
https://ncbi.nlm.nih.gov/pubmed/3215290
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items